AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,366,350 | -17.6% | 91,091 | -15.3% | 0.19% | -9.5% |
| Q2 2023 | $7,727,321 | +15.7% | 107,533 | -0.7% | 0.21% | +8.8% |
| Q1 2023 | $6,678,772 | +89740.9% | 108,281 | +12.3% | 0.19% | -17.2% |
| Q4 2022 | $7,434 | -99.8% | 96,386 | -9.8% | 0.23% | +51.3% |
| Q3 2022 | $4,767,000 | -11.9% | 106,839 | -24.4% | 0.15% | -5.5% |
| Q2 2022 | $5,411,000 | -21.1% | 141,284 | -14.7% | 0.16% | +0.6% |
| Q1 2022 | $6,857,000 | +52.1% | 165,656 | +38.9% | 0.16% | +80.0% |
| Q4 2021 | $4,507,000 | +18.0% | 119,298 | +2.9% | 0.09% | +13.9% |
| Q3 2021 | $3,821,000 | -59.2% | 115,939 | -16.6% | 0.08% | -53.0% |
| Q2 2021 | $9,373,000 | +28.9% | 138,935 | +8.2% | 0.17% | +24.4% |
| Q1 2021 | $7,270,000 | -39.0% | 128,405 | -12.2% | 0.14% | -40.5% |
| Q4 2020 | $11,921,000 | – | 146,325 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |